| HCC without metastasis (N = 63) | HCC with metastasis (N = 45) | Normal (N = 26) | |||
---|---|---|---|---|---|---|
Clinical variable | n | % | n | % | n | % |
Sex | Â | Â | Â | Â | Â | Â |
Male | 46 | 73.02% | 39 | 86.67% | 9 | 34.62% |
Female | 17 | 26.98% | 6 | 13.33% | 17 | 65.38% |
Age (years) | Â | Â | Â | Â | Â | Â |
≤ 50 | 33 | 52.38% | 24 | 53.33% | 16 | 61.54% |
>50 | 30 | 47.62% | 21 | 46.67% | 10 | 38.46% |
HBV | Â | Â | Â | Â | Â | Â |
+ | 63 | 100.00% | 45 | 100.00% | 26 | 100.00% |
- | Â | Â | Â | Â | Â | Â |
Liver cirrhosis | Â | Â | Â | Â | Â | Â |
Yes | 16 | 25.40% | 7 | 15.56% | 24 | 92.31% |
No | 47 | 74.60% | 37 | 82.22% | 2 | 7.69% |
Unknown | Â | Â | 1 | 2.22% | Â | Â |
Child-Pugh staging | Â | Â | Â | Â | Â | Â |
A | 40 | 63.49% | 36 | 80.00% | N/A | N/A |
B | 19 | 30.16% | 9 | 20.00% | N/A | N/A |
C | 4 | 6.35% | Â | Â | N/A | N/A |
Tumor size (cm) | Â | Â | Â | Â | Â | Â |
≤ 3 | 20 | 31.75% | 27 | 60.00% | N/A | N/A |
3~5 | 27 | 42.85% | 18 | 40.00% | N/A | N/A |
>5 | 16 | 25.40% | Â | Â | N/A | N/A |
Edmondson grade | Â | Â | Â | Â | Â | Â |
I | 3 | 4.76% | 2 | 4.44% | N/A | N/A |
II | 50 | 79.37% | 30 | 66.67% | N/A | N/A |
III | 8 | 12.70% | 9 | 20.00% | N/A | N/A |
Unknown | 2 | 3.17% | 4 | 8.89% | N/A | N/A |
AFP (ng/ml) | Â | Â | Â | Â | Â | Â |
≤ 20 | 27 | 42.86% | 14 | 31.11% | 25 | 96.15% |
20~200 | 11 | 17.46% | 13 | 28.89% | 1 | 3.85% |
>200 | 25 | 39.68% | 18 | 40.00% | Â | Â |